SAN DIEGO--(BUSINESS WIRE)--Hollis-Eden Pharmaceuticals, Inc. (NASDAQ:HEPH) today announced that it will conduct a conference call and live webcast on March 19, 2008 at 2:00 p.m. Eastern (11:00 a.m. Pacific) to review fourth quarter 2007 financial results and to update its drug development programs in metabolic disorders, inflammatory conditions and cancer. The Company will issue a news release on its financial results prior to the market opening on March 17, 2008.
